Life Sciences: Long-Acting Treatments in the Asia-Pacific

Health systems in the Asia-Pacific have long been under pressure. And, especially in light of the modern pandemic, budgets are more constrained than ever which is having a direct impact on access to medical innovation. In this article, we cover our experience with handling Long-Acting Treatments (LATs), particularly of the injectable variety, and examine how the lessons learned can be incorporated into broader health system transformation efforts such as community-based care models, preventative intervention, and the role of individual accountability in our well-being.